MPS3
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS III (NCT06614894) | Ozlem Goker-Alpan | 2024-12-01 |
| The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3) (NCT05705674) | Lysosomal and Rare Disorders Research and Treatment Center, Inc. | 2023-05-01 |
Track MPS3 automatically
Every clearance here is in the API, with alerts when new ones post.